Status:
COMPLETED
The CREATE Wellness Study
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Diabetes
Heart Disease
Eligibility:
All Genders
40-85 years
Phase:
NA
Brief Summary
Cardiovascular disease (CVD) is the leading cause of death in the U.S. Efforts to improve CVD risk factors often fall short in complex patients with multiple co-morbid conditions, a growing, expensive...
Detailed Description
Cardiovascular disease (CVD) is the leading cause of death in the U.S. Despite the availability of evidence-based guidelines and efficacious therapies, however, many patients do not achieve the full b...
Eligibility Criteria
Inclusion
- Kaiser Permanente Northern California members enrolled in the PHASE disease management program and not meeting all goals of care for the preceding 2 years.
Exclusion
- Schizophrenia or personality disorder
- Unable to communicate in English
- Unwilling to participate in group-based in-person program
- Pregnant
- Terminal or debilitating illness
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2018
Estimated Enrollment :
647 Patients enrolled
Trial Details
Trial ID
NCT02302612
Start Date
January 1 2015
End Date
September 30 2018
Last Update
October 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente San Jose Sabrina Wood, BA (510) 891-3551 Sabrina.B.Wood@kp.org
San Jose, California, United States, 95119